Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients

Daryl R. Fourney, Donald F. Schomer, Remi Nader, Jennifer Chlan-Fourney, Dima Suki, Kamran Ahrar, Laurence D. Rhines, Ziya L. Gokaslan

Research output: Contribution to journalArticle

Abstract

Object. The current North American experience with minimally invasive vertebro- and kyphoplasty is largely limited to the treatment of benign osteoporotic compression fractures. The objective of this study was to assess the safety and efficacy of these procedures for painful vertebral body (VB) fractures in cancer patients. Methods. The authors reviewed a consecutive group of cancer patients (21 with myeloma and 35 with other primary malignancies) undergoing vertebro- and kyphoplasty at their institution. Ninety-seven (65 vertebro- and 32 kyphoplasty) procedures were performed in 56 patients during 58 treatment sessions. The mean patient age was 62 years (± 13 years [standard deviation]) and the median duration of symptoms was 3.2 months. All patients suffered intractable spinal pain secondary to VB fractures. Patients noted marked or complete pain relief after 49 procedures (84%), and no change after five procedures (9%); early postoperative Visual Analog Scale (VAS) pain scores were unavailable in four patients (7%). No patient was worse after treatment. Reductions in VAS pain scores remained significant up to 1 year (p = 0.02, Wilcoxon signedrank test). Analgesic consumption was reduced at 1 month (p = 0.03, Wilcoxon signed test). Median follow-up length was 4.5 months (range 1 day-19.7 months). Asymptomatic cement leakage occurred during vertebroplasty at six (9.2%) of 65 levels; no cement extravasation was seen during kyphoplasty. There were no deaths or complications related to the procedures. The mean percentage of restored VB height by kyphoplasty was 42 ± 21%. Conclusions. Percutaneous vertebro- and kyphoplasty provided significant pain relief in a high percentage of patients, and this appeared durable over time. The absence of cement leakage-related complications may reflect the use of 1) high-viscosity cement; 2) kyphoplasty in selected cases; and 3) relatively small 3volume injection. Precise indications for these techniques are evolving; however, they are safe and feasible in well-selected patients with refractory spinal pain due to myeloma bone disease or metastases.

Original languageEnglish (US)
Pages (from-to)21-30
Number of pages10
JournalJournal of Neurosurgery
Volume98
Issue number1
StatePublished - Jan 1 2003

Fingerprint

Kyphoplasty
Vertebroplasty
Neoplasms
Intractable Pain
Pain Measurement
Compression Fractures
Pain
Osteoporotic Fractures
Body Height
Bone Diseases
Viscosity
Analgesics
Therapeutics

Keywords

  • Bone cement
  • Fracture
  • Kyphoplasty
  • Metastasis
  • Myeloma
  • Vertebroplasty

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Fourney, D. R., Schomer, D. F., Nader, R., Chlan-Fourney, J., Suki, D., Ahrar, K., ... Gokaslan, Z. L. (2003). Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. Journal of Neurosurgery, 98(1), 21-30.

Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. / Fourney, Daryl R.; Schomer, Donald F.; Nader, Remi; Chlan-Fourney, Jennifer; Suki, Dima; Ahrar, Kamran; Rhines, Laurence D.; Gokaslan, Ziya L.

In: Journal of Neurosurgery, Vol. 98, No. 1, 01.01.2003, p. 21-30.

Research output: Contribution to journalArticle

Fourney, DR, Schomer, DF, Nader, R, Chlan-Fourney, J, Suki, D, Ahrar, K, Rhines, LD & Gokaslan, ZL 2003, 'Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients', Journal of Neurosurgery, vol. 98, no. 1, pp. 21-30.
Fourney DR, Schomer DF, Nader R, Chlan-Fourney J, Suki D, Ahrar K et al. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. Journal of Neurosurgery. 2003 Jan 1;98(1):21-30.
Fourney, Daryl R. ; Schomer, Donald F. ; Nader, Remi ; Chlan-Fourney, Jennifer ; Suki, Dima ; Ahrar, Kamran ; Rhines, Laurence D. ; Gokaslan, Ziya L. / Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. In: Journal of Neurosurgery. 2003 ; Vol. 98, No. 1. pp. 21-30.
@article{a641a631e6b94de2aa53e5ad6623b324,
title = "Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients",
abstract = "Object. The current North American experience with minimally invasive vertebro- and kyphoplasty is largely limited to the treatment of benign osteoporotic compression fractures. The objective of this study was to assess the safety and efficacy of these procedures for painful vertebral body (VB) fractures in cancer patients. Methods. The authors reviewed a consecutive group of cancer patients (21 with myeloma and 35 with other primary malignancies) undergoing vertebro- and kyphoplasty at their institution. Ninety-seven (65 vertebro- and 32 kyphoplasty) procedures were performed in 56 patients during 58 treatment sessions. The mean patient age was 62 years (± 13 years [standard deviation]) and the median duration of symptoms was 3.2 months. All patients suffered intractable spinal pain secondary to VB fractures. Patients noted marked or complete pain relief after 49 procedures (84{\%}), and no change after five procedures (9{\%}); early postoperative Visual Analog Scale (VAS) pain scores were unavailable in four patients (7{\%}). No patient was worse after treatment. Reductions in VAS pain scores remained significant up to 1 year (p = 0.02, Wilcoxon signedrank test). Analgesic consumption was reduced at 1 month (p = 0.03, Wilcoxon signed test). Median follow-up length was 4.5 months (range 1 day-19.7 months). Asymptomatic cement leakage occurred during vertebroplasty at six (9.2{\%}) of 65 levels; no cement extravasation was seen during kyphoplasty. There were no deaths or complications related to the procedures. The mean percentage of restored VB height by kyphoplasty was 42 ± 21{\%}. Conclusions. Percutaneous vertebro- and kyphoplasty provided significant pain relief in a high percentage of patients, and this appeared durable over time. The absence of cement leakage-related complications may reflect the use of 1) high-viscosity cement; 2) kyphoplasty in selected cases; and 3) relatively small 3volume injection. Precise indications for these techniques are evolving; however, they are safe and feasible in well-selected patients with refractory spinal pain due to myeloma bone disease or metastases.",
keywords = "Bone cement, Fracture, Kyphoplasty, Metastasis, Myeloma, Vertebroplasty",
author = "Fourney, {Daryl R.} and Schomer, {Donald F.} and Remi Nader and Jennifer Chlan-Fourney and Dima Suki and Kamran Ahrar and Rhines, {Laurence D.} and Gokaslan, {Ziya L.}",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
volume = "98",
pages = "21--30",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "1",

}

TY - JOUR

T1 - Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients

AU - Fourney, Daryl R.

AU - Schomer, Donald F.

AU - Nader, Remi

AU - Chlan-Fourney, Jennifer

AU - Suki, Dima

AU - Ahrar, Kamran

AU - Rhines, Laurence D.

AU - Gokaslan, Ziya L.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Object. The current North American experience with minimally invasive vertebro- and kyphoplasty is largely limited to the treatment of benign osteoporotic compression fractures. The objective of this study was to assess the safety and efficacy of these procedures for painful vertebral body (VB) fractures in cancer patients. Methods. The authors reviewed a consecutive group of cancer patients (21 with myeloma and 35 with other primary malignancies) undergoing vertebro- and kyphoplasty at their institution. Ninety-seven (65 vertebro- and 32 kyphoplasty) procedures were performed in 56 patients during 58 treatment sessions. The mean patient age was 62 years (± 13 years [standard deviation]) and the median duration of symptoms was 3.2 months. All patients suffered intractable spinal pain secondary to VB fractures. Patients noted marked or complete pain relief after 49 procedures (84%), and no change after five procedures (9%); early postoperative Visual Analog Scale (VAS) pain scores were unavailable in four patients (7%). No patient was worse after treatment. Reductions in VAS pain scores remained significant up to 1 year (p = 0.02, Wilcoxon signedrank test). Analgesic consumption was reduced at 1 month (p = 0.03, Wilcoxon signed test). Median follow-up length was 4.5 months (range 1 day-19.7 months). Asymptomatic cement leakage occurred during vertebroplasty at six (9.2%) of 65 levels; no cement extravasation was seen during kyphoplasty. There were no deaths or complications related to the procedures. The mean percentage of restored VB height by kyphoplasty was 42 ± 21%. Conclusions. Percutaneous vertebro- and kyphoplasty provided significant pain relief in a high percentage of patients, and this appeared durable over time. The absence of cement leakage-related complications may reflect the use of 1) high-viscosity cement; 2) kyphoplasty in selected cases; and 3) relatively small 3volume injection. Precise indications for these techniques are evolving; however, they are safe and feasible in well-selected patients with refractory spinal pain due to myeloma bone disease or metastases.

AB - Object. The current North American experience with minimally invasive vertebro- and kyphoplasty is largely limited to the treatment of benign osteoporotic compression fractures. The objective of this study was to assess the safety and efficacy of these procedures for painful vertebral body (VB) fractures in cancer patients. Methods. The authors reviewed a consecutive group of cancer patients (21 with myeloma and 35 with other primary malignancies) undergoing vertebro- and kyphoplasty at their institution. Ninety-seven (65 vertebro- and 32 kyphoplasty) procedures were performed in 56 patients during 58 treatment sessions. The mean patient age was 62 years (± 13 years [standard deviation]) and the median duration of symptoms was 3.2 months. All patients suffered intractable spinal pain secondary to VB fractures. Patients noted marked or complete pain relief after 49 procedures (84%), and no change after five procedures (9%); early postoperative Visual Analog Scale (VAS) pain scores were unavailable in four patients (7%). No patient was worse after treatment. Reductions in VAS pain scores remained significant up to 1 year (p = 0.02, Wilcoxon signedrank test). Analgesic consumption was reduced at 1 month (p = 0.03, Wilcoxon signed test). Median follow-up length was 4.5 months (range 1 day-19.7 months). Asymptomatic cement leakage occurred during vertebroplasty at six (9.2%) of 65 levels; no cement extravasation was seen during kyphoplasty. There were no deaths or complications related to the procedures. The mean percentage of restored VB height by kyphoplasty was 42 ± 21%. Conclusions. Percutaneous vertebro- and kyphoplasty provided significant pain relief in a high percentage of patients, and this appeared durable over time. The absence of cement leakage-related complications may reflect the use of 1) high-viscosity cement; 2) kyphoplasty in selected cases; and 3) relatively small 3volume injection. Precise indications for these techniques are evolving; however, they are safe and feasible in well-selected patients with refractory spinal pain due to myeloma bone disease or metastases.

KW - Bone cement

KW - Fracture

KW - Kyphoplasty

KW - Metastasis

KW - Myeloma

KW - Vertebroplasty

UR - http://www.scopus.com/inward/record.url?scp=0037218717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037218717&partnerID=8YFLogxK

M3 - Article

C2 - 12546384

AN - SCOPUS:0037218717

VL - 98

SP - 21

EP - 30

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 1

ER -